CDKL3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.261800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.437200E-01
Normal-vs-Stage2
7.841400E-01
Normal-vs-Stage3
3.218200E-01
Normal-vs-Stage4
2.598000E-01
Stage1-vs-Stage2
7.586400E-02
Stage1-vs-Stage3
8.527700E-02
Stage1-vs-Stage4
9.415000E-01
Stage2-vs-Stage3
8.189600E-02
Stage2-vs-Stage4
1.071840E-01
Stage3-vs-Stage4
6.915700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.138400E-01
Normal-vs-AfricanAmerican
3.444200E-01
Normal-vs-Asian
5.879200E-01
Caucasian-vs-AfricanAmerican
6.210600E-01
Caucasian-vs-Asian
2.109700E-02
AfricanAmerican-vs-Asian
9.121900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.815800E-01
Normal-vs-Female
7.369200E-01
Male-vs-Female
5.725400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.331400E-01
Normal-vs-Age(41-60Yrs)
4.436600E-01
Normal-vs-Age(61-80Yrs)
8.169400E-01
Normal-vs-Age(81-100Yrs)
8.974000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.361000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.471600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.857000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.402200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.619600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.844200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.051000E-01
Normal-vs-Daily Drinker
3.824800E-01
Normal-vs-Weekly Drinker
8.127800E-01
Normal-vs-Occasional Drinker
5.755200E-01
Normal-vs-Social Drinker
4.102400E-01
Non Drinker-vs-Daily Drinker
2.715200E-01
Non Drinker-vs-Weekly Drinker
8.807200E-01
Non Drinker-vs-Occasional Drinker
1.398190E-01
Non Drinker-vs-Social Drinker
2.530100E-02
Daily Drinker-vs-Weekly Drinker
2.946800E-01
Daily Drinker-vs-Occasional Drinker
5.439400E-01
Daily Drinker-vs-Social Drinker
9.268400E-01
Weekly Drinker-vs-Occasional Drinker
1.669170E-01
Weekly Drinker-vs-Social Drinker
5.913500E-02
Occasional Drinker-vs-Social Drinker
2.992600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.011000E-01
Normal-vs-Grade 2
3.005000E-01
Normal-vs-Grade 3
5.621700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.826400E-01
Grade 1-vs-Grade 3
4.085200E-01
Grade 1-vs-Grade 4
2.011000E-01
Grade 2-vs-Grade 3
6.228200E-01
Grade 2-vs-Grade 4
3.005000E-01
Grade 3-vs-Grade 4
5.621700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.358600E-01
Normal-vs-NonDiabetic
7.183400E-01
Diabetic-vs-NonDiabetic
4.070000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.630400E-01
Normal-vs-NoPancreatitis
7.644800E-01
Pancreatitis-vs-NoPancreatitis
9.763800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.147200E-01
Normal-vs-N1
7.834800E-01
N0-vs-N1
2.043600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.979800E-01
Normal-vs-TP53-NonMutant
1.627160E-01
TP53-Mutant-vs-TP53-NonMutant
6.417900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
